Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-25-001282
Filing Date
2025-01-06
Accepted
2025-01-06 15:51:53
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm252097d1_424b3.htm 424B3 7304
2 GRAPHIC tm252097d1_img001.jpg GRAPHIC 10081
  Complete submission text file 0001104659-25-001282.txt   22445
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Filer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-265956 | Film No.: 25510922
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)